Research Progress
-
- Xin Lin's group reports "K63-linked ubiquitination regulates RIPK1 kinase activity to prevent cell death during embryogenesis and inflammation"
- Link: https://www.nature.com/articles/s41467-
-
- Wanli Liu's lab illustrated the PI(4,5)P2-derived “gasoline engine model” for the sustained B cell receptor activation in Immunological Reviews
- On August 12, 2019, a research team led by Dr. Wan
-
- Xiaoyu Hu's group reported that creatine plays important roles in regulating macrophage polarization in Immunity
- On August 6, 2019, Dr. Xiaoyu Hu’s group at
-
- Wanli Liu's group and colleagues report "FcγRIIB-I232Tpolymorphic change allosterically suppresses ligand binding"
- Link: https://elifesciences.org/articles/4668
-
- Postdoctoral Positions in the Yi Zhang lab at Harvard Medical School to study the mechanism and clinical application of eccDNAs in innate immunity
- Postdoctoral Positions in the Yi Zhang lab a
-
- Wanli Liu's lab revealed a novel mechanism of B cell receptor co-receptor FcRL1 to enhance B cell activation and function
- On July 17, 2019, Wanli Liu’s lab from Insti
-
- Wanli Liu's lab reported antigen-induced conformational changes within extracellular domain of B cell receptor in eLife
- On July 10th 2019, a research team led by Dr. Wanl
-
- Chen Dong's group reports "Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation"
- Link: https://immunology.sciencemag.org/conte
-
- Postdoctoral positions are available at Weill Cornell Medicine
- Postdoctoral position gut-lung-brain immune
-
- Xiaoyu Hu's group reported integration of intestinal epithelial nutrient sensing and host defense functions in Cell Host & Microbe
- On April 30, 2019, Dr. Xiaoyu Hu’s group at
-
- Xiaoyu Hu's group reported transcription factor Hes1 as a novel suppressor of type I IFNs
- A research article from Xiaoyu Hu’s Lab enti
-
- Wanli Liu's group reports "Degradation of Bruton’s tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant Non-Hodgkin lymphomas"
- Link: https://www.nature.com/articles/s41375-
